Arax Advisory Partners’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.82K | Sell |
61
-56
| -48% | -$7.18K | ﹤0.01% | 2077 |
|
|
2025
Q1 | $10.4K | Buy |
117
+67
| +134% | +$5.93K | ﹤0.01% | 1556 |
|
|
2024
Q4 | $4.36K | Sell |
50
-7
| -12% | -$611 | ﹤0.01% | 1786 |
|
|
2024
Q3 | $5.27K | Sell |
57
-5
| -8% | -$463 | ﹤0.01% | 1698 |
|
|
2024
Q2 | $6.68K | Buy |
62
+56
| +933% | +$6.04K | ﹤0.01% | 1458 |
|
|
2024
Q1 | $570 | Hold |
6
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q4 | $554 | Buy |
+6
| New | +$554 | ﹤0.01% | 1215 |
|
|
2023
Q2 | – | Sell |
-7
| Closed | -$315 | – | 1276 |
|
|
2023
Q1 | $315 | Hold |
7
| – | – | ﹤0.01% | 1226 |
|
|
2022
Q4 | $307 | Buy |
+7
| New | +$307 | ﹤0.01% | 1215 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$1K | – | 1155 |
|
|
2021
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 974 |
|
|
2021
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 880 |
|